IgG4-Related Disease Latest Advances

Find the Latest Research About IgG4-Related Disease

Find a DoctorCondition OverviewLatest AdvancesClinical TrialsTreatments

Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011.

Journal: Modern Rheumatology
Published: October 14, 2011
Abstract

Background: IgG4-related disease (IgG4-RD) is a novel clinical disease entity characterized by elevated serum IgG4 concentration and tumefaction or tissue infiltration by IgG4+ plasma cells. Although IgG4-RD is not rare and is clinically important, its clinical diagnostic criteria have not been established. Comprehensive diagnostic criteria for IgG4-RD, including the involvement of various organs, are intended for the practical use of general physicians and nonspecialists.

Methods: Two IgG4-RD study groups, the Umehara and Okazaki teams, were organized by the Ministry of Health, Labor and Welfare Japan. As IgG4-RD comprises a wide variety of diseases, these groups consist of physicians and researchers in various disciplines, including rheumatology, hematology, gastroenterology, nephrology, pulmonology, ophthalmology, odontology, pathology, statistics, and basic and molecular immunology throughout Japan, with 66 and 56 members of the Umehara and Okazaki teams, respectively. Collaborations of the two study groups involved detailed analyses of clinical symptoms, laboratory results, and biopsy specimens of patients with IgG4-RD, resulting in the establishment of comprehensive diagnostic criteria for IgG4-RD.

Results: Although many patients with IgG4-RD have lesions in several organs, either synchronously or metachronously, and the pathological features of each organ differ, consensus has been reached on two diagnostic criteria for IgG4RD: (1) serum IgG4 concentration >135 mg/dl, and (2) >40% of IgG+ plasma cells being IgG4+ and >10 cells/high powered field of biopsy sample. Although the comprehensive diagnostic criteria are not sufficiently sensitive for the diagnosis of type 1 IgG4-related autoimmune pancreatitis (IgG4-related AIP), they are adequately sensitive for IgG4-related Mikulicz's disease (MD) and kidney disease (KD). In addition, the comprehensive diagnostic criteria, combined with organ-specific diagnostic criteria, have increased the sensitivity of diagnosis to 100% for IgG4-related MD, KD, and AIP.

Conclusions: Our comprehensive diagnostic criteria for IgG4-RD are practically useful for general physicians and nonspecialists.

Authors
Hisanori Umehara, Kazuichi Okazaki, Yasufumi Masaki, Mitsuhiro Kawano, Motohisa Yamamoto, Takako Saeki, Shoko Matsui, Tadashi Yoshino, Shigeo Nakamura, Shigeyuki Kawa, Hideaki Hamano, Terumi Kamisawa, Toru Shimosegawa, Akira Shimatsu, Seiji Nakamura, Tetsuhide Ito, Kenji Notohara, Takayuki Sumida, Yoshiya Tanaka, Tsuneyo Mimori, Tsutomu Chiba, Michiaki Mishima, Toshifumi Hibi, Hirohito Tsubouchi, Kazuo Inui, Hirotaka Ohara
Relevant Conditions

IgG4-Related Disease, Interstitial Nephritis, Acute Pancreatitis, Mikulicz Disease, Hereditary Pancreatitis

Similar Publications

Are Classification Criteria for IgG4-RD Now Possible? The Concept of IgG4-Related Disease and Proposal of Comprehensive Diagnostic Criteria in Japan.
Are Classification Criteria for IgG4-RD Now Possible? The Concept of IgG4-Related Disease and Proposal of Comprehensive Diagnostic Criteria in Japan.
Journal: International journal of rheumatology
Published: November 09, 2011
The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD.
The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD.
Journal: Modern rheumatology
Published: December 04, 2020
Proposal of diagnostic criteria for IgG4-related thyroid disease.
Proposal of diagnostic criteria for IgG4-related thyroid disease.
Journal: Endocrine journal
Published: December 14, 2020
View All
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

Bullet PinMediFind
Follow us on
This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
© 2025 All Rights Reserved